Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

NCT00995241 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir

Sponsor

Germans Trias i Pujol Hospital

Collaborators

[object Object]